A study led by UMass Chan Medical School researchers has demonstrated that a gene therapy to correct a mutation that causes ...

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

Using this cis-activation strategy in primary cells and muscle, we have demonstrated an increase in transgene expression of more than 600-fold from a minimal simian virus 40 (SV40) promoter and an ...

After figuring out how to grow recombinant bacteria on an industrial scale and how to harvest the insulin they produce, it was time to bring the recombinant insulin to the market. In 1982 Food and ...

The Food and Drug Administration (FDA) has granted accelerated approval to Vimkunya™ (chikungunya vaccine, recombinant) for the prevention of disease caused by chikungunya virus (CHIKV) in individuals ...

The outbreak of Ebola virus in West Africa in 2014-16 killed more than 11,000 people. Vaccination is vital for disease control. A recombinant Ebola virus vaccine, jointly developed by Beijing ...

Janet Mertz’s work with simian virus 40 DNA during her graduate years was pivotal for developing DNA recombination as we now know it. Berg was awarded one-half of the Nobel Prize in Chemistry in 1980 ...

The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...

Recombinant DNA is one of the first stories in modern biotechnology history. The National Museum of American History contains collections which trace this foundational technique of genetic engineering ...